Novo Nordisk A/S Profile Avatar - Palmy Investing

Novo Nordisk A/S

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment pro…
Biotechnology
DK, Bagsvaerd [HQ]

Balance Sheet

15 Sheets · Starting from 2023
In Million DKK. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Assets
54,742.00 61,402.00 64,698.00 65,669.00 70,337.00 77,062.00 91,799.00 97,539.00 102,355.00 110,769.00 125,612.00 144,922.00 194,508.00 241,257.00 314,486.00
Current
32,666.00 37,293.00 39,591.00 40,163.00 42,058.00 46,293.00 55,140.00 59,766.00 60,080.00 59,067.00 62,456.00 65,809.00 85,595.00 108,194.00 139,646.00
Non Current
22,076.00 24,109.00 25,107.00 25,506.00 28,279.00 30,769.00 36,659.00 37,773.00 42,275.00 51,702.00 63,156.00 79,113.00 108,913.00 133,063.00 174,840.00
Liabilities
19,008.00 24,437.00 27,250.00 25,037.00 27,768.00 36,768.00 44,830.00 52,270.00 52,540.00 58,930.00 68,019.00 81,597.00 123,762.00 157,771.00 207,925.00
Current
13,415.00 18,476.00 20,779.00 21,638.00 24,225.00 33,689.00 40,873.00 47,436.00 47,056.00 54,164.00 58,983.00 70,273.00 99,516.00 120,940.00 169,655.00
Non Current
5,593.00 5,961.00 6,471.00 3,399.00 3,543.00 3,079.00 3,957.00 4,834.00 5,484.00 4,766.00 9,036.00 11,324.00 24,246.00 36,831.00 38,270.00
Equity
35,734.00 36,965.00 37,448.00 40,632.00 42,569.00 40,294.00 46,969.00 45,269.00 49,815.00 51,839.00 57,593.00 63,325.00 70,746.00 83,486.00 106,561.00
Stockholders' Equity
35,734.00 36,965.00 37,448.00 40,632.00 42,569.00 40,294.00 46,969.00 45,269.00 49,815.00 51,839.00 57,593.00 63,325.00 70,746.00 83,486.00 106,561.00
Retained Earnings
35,146.00 36,097.00 37,111.00 39,001.00 41,137.00 41,277.00 46,816.00 46,111.00 48,977.00 53,406.00 57,817.00 63,774.00 72,004.00 80,587.00 104,839.00
Common Stock
620.00 600.00 580.00 560.00 550.00 530.00 520.00 510.00 500.00 490.00 480.00 470.00 462.00 456.00 451.00
Preferred Stock
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Profit
10,768.00 14,403.00 17,097.00 21,432.00 25,184.00 26,481.00 34,860.00 37,925.00 38,130.00 38,628.00 38,951.00 42,138.00 47,757.00 55,525.00 83,683.00
Dividends
- - -4,400.00 -5,700.00 -7,742.00 -9,715.00 -11,866.00 -12,905.00 -23,830.00 -18,844.00 -19,048.00 -19,409.00 -20,121.00 -21,517.00 -25,303.00 -31,767.00
Minority Interest
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Stockholders' Equity
-32.00 17,979.00 19,166.00 -17.00 -21.00 -11.00 -10.00 -9.00 -11.00 -11.00 -10.00 -8.00 -6.00 -6.00 -5.00
Loss Other Compr. Income
- - -17,711.00 -19,409.00 1,088.00 903.00 -1,502.00 -357.00 -1,343.00 349.00 -2,046.00 -694.00 -911.00 -1,714.00 2,449.00 1,276.00
End of NVO's Analysis
CIK: 353278 CUSIP: 670100205 ISIN: US6701002056 LEI: - UEI: -
Secondary Listings